SCHEMBL25872232

SCHEMBL25872232

COc1cc(N2CCC3(CCN(CC(=O)O)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)[SH]=O)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 17/20 0.59
▸ EGFR P00533 4/20 0.59
▸ INSR P06213 5/20 0.56
▸ IGF1R P08069 3/20 0.56
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ MAPK8 P45983 2/20 0.53
▸ MAPK9 P45984 2/20 0.53
▸ MAPK10 P53779 2/20 0.53
▸ MET P08581 2/20 0.53
▸ MAP3K7 O43318 1/20 0.53
▸ CDC7 O00311 1/20 0.53
▸ PLK4 O00444 1/20 0.53
▸ CHEK1 O14757 1/20 0.53
▸ AURKA O14965 1/20 0.53
▸ DCLK1 O15075 1/20 0.53
▸ PDPK1 O15530 1/20 0.53
▸ DAPK3 O43293 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26495709 0.90 EGFR (0.67) ALKEGFRINSRIGF1RMET
SCHEMBL25871927 0.89 ALK (0.62) ALKEGFRINSRIGF1RCYP3A4
Hydrochloric Acid SCHEMBL25261966 0.89 EGFR (0.66) ALKEGFRINSRIGF1RMET
SCHEMBL25871978 0.89 ALK (0.60) ALKEGFRINSRIGF1RMET
SCHEMBL25872148 0.88 ALK (0.73) ALKEGFRINSRIGF1RMET
SCHEMBL25872145 0.87 ALK (0.66) ALKEGFR
SCHEMBL29059803 0.85 ALK (0.62) ALKEGFRINSRIGF1RMAPK8
SCHEMBL25870332 0.85 ALK (0.60) ALKEGFRINSRIGF1RMET
SCHEMBL25869800 0.83 ALK (0.75) ALKEGFRINSRIGF1RMET
SCHEMBL25870490 0.83 ALK (0.58) ALKEGFRINSRIGF1RMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4212522-A1 COMPOUNDS FOR SUPPRESSING EGFR MUTANT CANCER AND PHARMACEUTICAL USE THEREOF J2H Biotech Inc. (KR) 2023-07-19 — — EP disclosed
Send feedback